Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Diagnostic Laboratory, |
RCV000202911 | SCV000257698 | benign | not specified | 2015-07-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002057040 | SCV002450817 | benign | not provided | 2023-12-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002057040 | SCV002525262 | uncertain significance | not provided | 2021-11-30 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34321610) |
Ce |
RCV002057040 | SCV004150133 | likely benign | not provided | 2023-02-01 | criteria provided, single submitter | clinical testing | HOXD13: BS2 |
Prevention |
RCV004553104 | SCV004752271 | likely benign | HOXD13-related disorder | 2019-08-12 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |